332 related articles for article (PubMed ID: 34721568)
1. Levodopa Challenge Test Predicts STN-DBS Outcomes in Various Parkinson's Disease Motor Subtypes: A More Accurate Judgment.
Zheng Z; Yin Z; Zhang B; Fan H; Liu D; Zhou Y; Duan J; Zhou D; Wu X; Lu G
Neural Plast; 2021; 2021():4762027. PubMed ID: 34721568
[TBL] [Abstract][Full Text] [Related]
2. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY
Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833
[TBL] [Abstract][Full Text] [Related]
4. Relationship between electrode position of deep brain stimulation and motor symptoms of Parkinson's disease.
Zhang F; Wang F; Li W; Wang N; Han C; Fan S; Li P; Xu L; Zhang J; Meng F
BMC Neurol; 2021 Mar; 21(1):122. PubMed ID: 33731033
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
[TBL] [Abstract][Full Text] [Related]
6. Quality of life in advanced Parkinson's disease after bilateral subthalamic stimulation: 2 years follow-up study.
Sobstyl M; Ząbek M; Górecki W; Mossakowski Z
Clin Neurol Neurosurg; 2014 Sep; 124():161-5. PubMed ID: 25051167
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
[TBL] [Abstract][Full Text] [Related]
8. Effects of deep brain stimulation of the subthalamic nucleus on freezing of gait in Parkinson's disease: a prospective controlled study.
Vercruysse S; Vandenberghe W; Münks L; Nuttin B; Devos H; Nieuwboer A
J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):871-7. PubMed ID: 24396010
[TBL] [Abstract][Full Text] [Related]
9. Differential Effects of Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation on Motor Subtypes in Parkinson's Disease.
Fan S; Liu D; Shi L; Meng F; Fang H; Liu H; Zhang H; Yang A; Zhang J
World Neurosurg; 2022 Aug; 164():e245-e255. PubMed ID: 35489598
[TBL] [Abstract][Full Text] [Related]
10. Medication dose reductions after pallidal versus subthalamic stimulation in patients with Parkinson's disease.
Evidente VG; Premkumar AP; Adler CH; Caviness JN; Driver-Dunckley E; Lyons MK
Acta Neurol Scand; 2011 Sep; 124(3):211-4. PubMed ID: 20969559
[TBL] [Abstract][Full Text] [Related]
11. Stratifying quality of life outcome in subthalamic stimulation for Parkinson's disease.
Gronostay A; Jost ST; Silverdale M; Rizos A; Loehrer PA; Evans J; Sauerbier A; Indi D; Leta V; Reker P; Fink GR; Ashkan K; Antonini A; Nimsky C; Visser-Vandewalle V; Martinez-Martin P; Ray Chaudhuri K; Timmermann L; Dafsari HS
J Neurol Neurosurg Psychiatry; 2024 Jun; 95(7):630-638. PubMed ID: 38124227
[TBL] [Abstract][Full Text] [Related]
12. Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease.
Mueller K; Jech R; Růžička F; Holiga Š; Ballarini T; Bezdicek O; Möller HE; Vymazal J; Růžička E; Schroeter ML; Urgošík D
Neuroimage Clin; 2018; 19():1025-1035. PubMed ID: 30035027
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of deep brain stimulation target on motor subtypes in Parkinson's disease.
Katz M; Luciano MS; Carlson K; Luo P; Marks WJ; Larson PS; Starr PA; Follett KA; Weaver FM; Stern MB; Reda DJ; Ostrem JL;
Ann Neurol; 2015 Apr; 77(4):710-9. PubMed ID: 25627340
[TBL] [Abstract][Full Text] [Related]
14. Eight-year follow-up outcome of subthalamic deep brain stimulation for Parkinson's disease: Maintenance of therapeutic efficacy with a relatively low levodopa dosage and stimulation intensity.
Jiang L; Chen W; Guo Q; Yang C; Gu J; Xian W; Liu Y; Zheng Y; Ye J; Xu S; Hu Y; Wu L; Chen J; Qian H; Fu X; Liu J; Chen L
CNS Neurosci Ther; 2021 Nov; 27(11):1366-1373. PubMed ID: 34350691
[TBL] [Abstract][Full Text] [Related]
15. SW2-year outcomes of subthalamic deep brain stimulation for idiopathic Parkinson's disease.
Nunta-Aree S; Sitthinamsuwan B; Boonyapisit K; Pisarnpong A
J Med Assoc Thai; 2010 May; 93(5):529-40. PubMed ID: 20524438
[TBL] [Abstract][Full Text] [Related]
16. Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients.
Tir M; Devos D; Blond S; Touzet G; Reyns N; Duhamel A; Cottencin O; Dujardin K; Cassim F; Destée A; Defebvre L; Krystkowiak P
Neurosurgery; 2007 Aug; 61(2):297-304; discussion 304-5. PubMed ID: 17762742
[TBL] [Abstract][Full Text] [Related]
17. Effect of Subthalamic Deep Brain Stimulation on Levodopa-Induced Dyskinesia in Parkinson's Disease.
Kim JH; Chang WS; Jung HH; Chang JW
Yonsei Med J; 2015 Sep; 56(5):1316-21. PubMed ID: 26256974
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of bilateral subthalamic stimulation on alexithymia in Parkinson's disease.
Dafsari HS; Ray-Chaudhuri K; Mahlstedt P; Sachse L; Steffen JK; Petry-Schmelzer JN; Dembek TA; Reker P; Barbe MT; Visser-Vandewalle V; Fink GR; Timmermann L
Eur J Neurol; 2019 Feb; 26(2):222-e17. PubMed ID: 30107062
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
[TBL] [Abstract][Full Text] [Related]
20. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
Dafsari HS; Martinez-Martin P; Rizos A; Trost M; Dos Santos Ghilardi MG; Reddy P; Sauerbier A; Petry-Schmelzer JN; Kramberger M; Borgemeester RWK; Barbe MT; Ashkan K; Silverdale M; Evans J; Odin P; Fonoff ET; Fink GR; Henriksen T; Ebersbach G; Pirtošek Z; Visser-Vandewalle V; Antonini A; Timmermann L; Ray Chaudhuri K;
Mov Disord; 2019 Mar; 34(3):353-365. PubMed ID: 30719763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
